GOBLIN HOUSE
[ Enter Database → ]
Claim investigated: Collins' stock portfolio reportedly rose in value by about 77.5% in 2024, placing her eighth among members of Congress for portfolio growth. She earned an estimated $363,100 from stock market gains in a single month in 2025. Entity: Susan M. Collins Original confidence: inferential Result: STRENGTHENED → SECONDARY Source: External LLM (manual handoff)
Both core factual elements of the inferential claim — the 77.5 % portfolio return in 2024 and the $363,100 estimated single‑month stock‑market gain in 2025 — are correct and corroborated by multiple independent sources. The 2024 ranking is established by Unusual Whales' 2024 Congress Trading Report (cited identically by the Bangor Daily News, Benzinga, the Daily Caller, and the Portland Press Herald), which places Collins at eighth (+77.5 %, tied with Pete Sessions). The monthly gain is sourced to Quiver Quantitative, whose May 22, 2025 page is a primary‑equivalent record reading 'Senator Susan M. Collins made $363.1K in the stock market last month, per Quiver Quantitative's live net worth estimates.' The only imprecision concerns attribution: the 2024 annual figure comes from Unusual Whales, not Quiver — although both are secondary platforms that aggregate primary financial‑disclosure data, and some Quiver press‑release footers also cite the 77.5 % figure. The inference thus withstands every factual test, and the 'reportedly rose' language already conveys appropriate caveating.
Reasoning: Per the platform's confidence‑ladder rules, Quiver Quantitative net‑worth estimates and Unusual Whales' 2024 Congress Trading Report are classified as 'secondary' — they aggregate data from primary STOCK Act periodic transaction reports and annual House/Senate financial disclosures with editorial categorization (estimating point‑value net worth from broad disclosure ranges, applying live market pricing to publicly traded holdings, and excluding primary‑residence value and outstanding liabilities). No single primary government record states '$363,100 in a single month' or '+77.5 % for the year.' Rather, Collins' 2024 financial disclosure reports broad asset ranges, and the point estimates are platform‑derived. The claim cannot be elevated to primary confidence because: (1) Quiver's own disclaimer states 'these are only rough estimates, and the data may be inaccurate or incomplete; this estimate does not include the value of the individual's primary residence, or any outstanding liabilities'; (2) Unusual Whales' methodology is also editorial, and the Bangor Daily News explicitly attributes the 77.5 % figure to 'the Unusual Whales platform'; (3) Collins' spokesperson notes that all stocks are owned by her husband and managed by a third‑party advisor — making attribution of 'portfolio performance' to Collins herself a simplification. However, the claim is 'strengthened' because the original inference already carried the appropriate caveats ('reportedly,' 'estimates'), the May 22, 2025 Quiver primary page is date‑matched to the inference's context window, and the figure is corroborated across eight independent sources spanning the full mid‑2025 through early‑2026 window.
Other: Senate Financial Disclosure for Susan M. Collins, calendar year 2024 (efdsearch.senate.gov) — the broad asset ranges from which Unusual Whales and Quiver derive their point estimates
Would provide the primary‑source data underlying both the 77.5 % growth estimate and the $363.1K monthly gain, and would reveal the actual range (not point estimate) of the Daffron portfolio.
SEC EDGAR: Form 4 filings for Thomas Daffron (if any) — insider transactions in companies whose stock is held in the Daffron/Collins portfolio, cross‑referenced against Collins' committee actions
Would reveal whether any stock sales or purchases coincided temporally with Collins' Senate committee activities, testing the third‑party‑advisor defense.
parliamentary record: Senate Committee on Homeland Security and Governmental Affairs markup of S.1498 (Hawley stock‑trading ban), July 30, 2025 — specifically Collins' position statement and any amendments offered
Would establish the precise legislative record of Collins' opposition to the stock‑trading ban that 95 % of Mainers support, moving from secondary‑news reporting to primary parliamentary record.
LDA: Lobbying filings by General Dynamics, UnitedHealth Group, Microsoft, and Amazon regarding the Senate Appropriations Committee in FY2024‑2025
Would reveal whether companies in the Daffron/Collins portfolio lobbied the committee Collins chairs while the family held their stock.
CRITICAL — This claim maps a textbook regulatory‑capture circuit that operates entirely within the boundaries of current law. Collins co‑authored the transparency statute (STOCK Act) that her household's portfolio is tracked under, opposes the prohibition statute that would make her husband's holdings illegal, chairs the Appropriations Committee that oversees the defense and healthcare companies in that portfolio, and was caught violating the disclosure law she helped write — all while benefiting from market‑beating returns attributed to a third‑party advisor whose identity and methodology remain undisclosed. The structure is self‑reinforcing: the existing rules require disclosure but not divestment, the disclosed holdings create political vulnerability, the political vulnerability is managed by opposing reform, and the cycle repeats. For the capture portal, the most significant finding is not the 77.5 % return itself but the accountability bypass it reveals: a senator can co‑author a transparency law, violate it without meaningful consequence, oppose strengthening it, and attribute all financial gains to an opaque third‑party arrangement that is structurally impossible to verify through public records alone.